ASKA PHARMACEUTICAL HOLDINGS CO LTD financial statements, including revenue, expenses, profit, and loss
The total revenue of 4886 for the last quarter is 17.18 B JPY, and it's 9.93% higher compared to the previous quarter. The net income of Q3 23 is 2.33 B JPY.